Tailored information and supportive care important interventions for breast and gynaecological cancer patients: Study

The most common cancer among women is breast cancer. The fifth
leading localisation for cancer is the uterus, especially corpus uteri. More
than 3% of female cancer is caused by ovarian cancer. Summing up about 40% of
female patients with cancer are affected by gynaecological malignancies
and breast cancer. Since patients with cancer are confronted with physical
symptoms, psychological and psychosocial problems especially during treatment,
health care providers have to focus on patients’ needs. Unmet supportive care
needs can lead to reduced quality of life and decreased compliance, with
worsened outcomes. Saskia‑Laureen Herbert and team investigated supportive
care needs and quality of life among women with breast cancer and
gynaecological cancer during the period of treatment.

Supportive care can be defined as the provision of necessary
support meeting informational, physical, social, and emotional needs. These
needs can be felt differently and differ between patients. “During the time of
treatment” is defined as a visit in hospital for either surgery or
neoadjuvant/adjuvant/palliative systemic therapy, which allows distinguishing
local and systemic issues. Supportive care needs can be identified by health
care providers. Felt needs and professionally captured needs are not always
matching.

Treatment of breast cancer and gynaecological cancer shows
acute as well as long-term side effects. Severity is dependent on personal
factors such as age and comorbidities as well as the type of therapy. Patients
with breast cancer and gynaecological cancer can be affected by general
symptoms as well as specific toxicities such as pain, nausea, vomiting,
fatigue, insomnia, alopecia, stomatitis, myelosuppression, lymphedema,
premature menopause and thromboembolism caused by therapy. These sequelae
require supportive care. Besides, psychological and social complications can
also affect patients with cancer and lead to decreased quality of life.
Many patients with breast cancer suffer from distress caused by therapy,
fear of recurrence, different body image as well as changes in sexuality.
Although effective interventions improved quality of life in patients with
breast cancer during the last years there are still many issues that require
further consideration in order to improve quality of life. For patients with gynaecological
cancer, it is already known that treatment with chemotherapy still leads to a
lower quality of life and lower involvement in social activities.

Improving supportive care during treatment of breast cancer
and gynaecological cancer is of great importance concerning management of
treatment related symptoms, increasing adherence to treatment, and addressing
psychological and social aspects of cancer and cancer treatment. Hence, meeting
supportive care needs should be a part of interdisciplinary cancer care
requiring education of health care providers and patient awareness of
supportive care services.

This study had three aims: (1) to identify information and
supportive care needs and to explore to which extent they are met in patients
with breast cancer compared to patients with gynaecological cancer
during the time of treatment; (2) to examine associations between information/
supportive care needs and sociodemographic and medical parameters; (3) to
explore the associations between information/supportive care needs and quality
of life.

In this German prospective study, authors enrolled 292
patients with breast cancer and gynaecological cancer during the time of
treatment. Data on needs were assessed using instruments that had proven
feasible in earlier studies. Data on quality of life (QoL) were assessed using
the European Organization for Research and Treatment of Cancer QoL Core Questionnaire
(EORTC QLQ-C30). They investigated correlations between needs and
sociodemographic data as well as quality of life.

Among all cancer entities authors observed that 150 patients
(51.5%) showed unmet information needs, 221 patients (75.7%) showed at least
one high supportive care need, and 91 patients (31.2%) had psychological care
needs. Data showed statistically significant correlations between these needs
and sociodemographic data as well as quality of life. These correlations
generally showed small to medium effect sizes.

Older women showed less supportive care needs
(r=− 0.24; p<0.001), (r=− 0.15; p=0.010).

Furthermore, recruitment after surgery was associated with
statistically significant higher information needs (r=0.14; p=0.015), whereas
recruitment during chemotherapy was associated with statistically significant
less information needs (r=− 0.15; p=0.013).

Positive correlations were shown for the level of received
information and physical functioning (r=0.12; p=0.047), social functioning
(r=0.16; p=0.009) and global quality of life (r=0.19, p=0.002) as well as
satisfaction with information and physical (r=0.16; p=0.006), social (r=0.24;
p<0.001), cognitive functioning (r=0.14; p=0.017) as well as global quality
of life (r=0.25; p<0.001).

Negative correlations were reported for information needs
and emotional functioning (r=− 0.12; p=0.035) and global quality of life
(r=− 0.15; p=0.011).

Supportive care needs also correlated negatively with
physical (r=− 0.23; p0.001), emotional (r=− 0.35; p<0.001), cognitive
(r=− 0.24; p<0.001), social functioning (r=− 0.30; p<0.001), and
global quality of life (r=− 0.35; p<0.001).

Also, patients with at least one high supportive care need
correlated negatively with role (r=− 0.15; p=0.014), emotional
(r=− 0.23; p<0.001), social functioning (r=− 0.30; p=0.001), and
global quality of life (r=− 0.35; p0.001). There was no statistical significance
concerning cancer side. Thus, both groups are reported together. Furthermore,
there was no statistical significance concerning disease status.

In this study, authors analysed needs and quality of life of
patients with breast cancer and gynaecological cancer during the time of
treatment. Overall, the results suggest that cancer patients still experience
an unacceptable level of unmet needs which can reduce quality of life.

This data indicated that unmet needs, particularly regarding
information and supportive care, are associated with poorer quality of life. By
focusing on patient-oriented conversations, healthcare providers can more effectively
identify individual concerns and tailor support accordingly. This approach
fosters a deeper understanding of each patient’s unique needs, allowing for
more personalized care and ultimately improving patient outcomes. Based on the findings
of this study, authors assume that a more patient-oriented communication
approach as part of routine care could be beneficial.

Source: Saskia‑Laureen Herbert, A. S. Payerl,
M. Prange; Archives of Gynecology and Obstetrics

https://doi.org/10.1007/s00404-024-07805-7

Powered by WPeMatico

Sublingual varices predictor of factors associated with cardiovascular diseases

A study published in Oral Maxillofacial Surgery suggests that sublingual varices are predictor of factors associated with cardiovascular diseases.

Sublingual varicose veins are variations of normality that appear more prominent during ageing. The systematic review aims to investigate sublingual varicose veins frequency in patients exposed to systemic and environmental exposure factors linked to cardiovascular diseases. This systematic review was based on the PECO strategy, and the PubMed, Web of Science, Scopus, Embase and Grey Literature library were searched for publications examining the association between sublingual varicose veins and systemic and environmental exposure factors linked to cardiovascular diseases, such as hypertension, diabetes, smoking, and leg varices. A meta-analysis was conducted using random-effects models. This review included 11 studies with 2,272 patients with sublingual varicosity and systemic exposed factors linked to cardiovascular diseases. The quality assessment was improved by Newcastle and Ottawa Scales (NOS). Results: Consistent results were observed across all systemic and environmental exposed factors linked to cardiovascular disease subgroups. We found association between sublingual varicose veins and hypertension [p = 0.0002; 95%IC2.90 [1.66-5.06]; I2 91%); diabetics (p = 0.009; 95%IC 3.19 [1.34 – 7.62]; I2 84%); tobacco abuse (p = 0.002; 95%IC 1.97 [1.29 – 3.01]; I2 82%) and leg varicosity (p = 0.03; 95%IC 2.63 [1.08 – 6.44]; I2 95%). Seven articles received score 7, indicating good quality and four articles received moderate quality. Patients exposed to exposed factors that affect blood vessels showed a higher prevalence of sublingual varicose veins. These findings emphasize the importance of recognizing oral signs underlying systemic diseases.
Reference:
Costa AKLS, de Andrade ACM, Felix FA, Pureza IROM, Nóbrega DF, de França GM. Sublingual varices as predictor of factors associated with cardiovascular diseases: A systematic review with meta-analysis. Oral Maxillofac Surg. 2024 Dec 3;29(1):15.
doi:10.1007/s10006-024-01311-5.PMID: 39623150
Keywords:
Costa AKLS, de Andrade ACM, Felix FA, Pureza IROM, Nóbrega DF, de França GM, Sublingual, varices, predictor, factors, cardiovascular diseases, systematic review, meta-analysis, Oral Maxillofacial Surgery, Heart disease risk factors; Mouth floor; Tongue; Varicose veins.

Powered by WPeMatico

Supreme Court Extends NEET 2024 Admissions Deadline till December 30

New Delhi: Observing that precious medical seats should not be wasted, the Supreme Court has extended the deadline for National Eligibility-Entrance Test Undergraduate (NEET-UG) admissions till December 30 as a “last chance”.

The Apex Court bench comprising Justices BR Gavai and KV Viswanathan granted the extension after taking into account the number of medical seats remaining vacant despite 5 rounds of counselling.

A batch of pleas/miscellaneous applications were filed with a prayer for directions to the Admission Authorities to conduct stray/special counselling round for the seats remaining vacant even after five (5) rounds of counselling. One of the pleas was for the conversion of one NRI seat which is vacant to the Management quota.

During the case proceedings, the senior counsel appearing for the National Medical Commission (NMC) submitted that in view of the number of vacant seats as a one-time measure, without it being treated as a precedent, the Court may extend the period. The Court also noted that one miscellaneous application had also been filed by NMC for approval of the extended time limit. 

Also Read: Supreme Court relief to disabled MBBS aspirant, supernumerary seat to be created

Accordingly, the top court bench observed,

“Taking into consideration the peculiar facts and circumstances and further that the precious medical seats should not go in waste, when the country is facing acute shortage of Doctors, we are inclined to extend the period by way of a last chance.”

Therefore, the Court directed the Admission Authorities to hold a fresh stray/special counselling for the seats remaining vacant and complete the admission process before 30.12.2024 in any eventuality.

“It is further directed that no college would be permitted to admit the students directly and admission should be conducted only through the State Admission Authorities,” ordered the Apex Court.

However, the Court also clarified that “the stray/special admission process should not disturb the admission which are already finalized and the admissions would be made only from the waitlisted candidates.”

Regarding the NRI seat which is vacant, the top court bench ordered to convert it into the General Category Quota. However, the bench said that the seat should be filled through the State Admission Authorities.

“The writ petitions and miscellaneous applications, including pending applications, if any, are disposed of,” stated the order.

To view the Supreme Court order, click on the link below:

https://medicaldialogues.in/pdf_upload/supreme-court-neet-ug-admission-deadline-265819.pdf

Also Read: MBBS Admissions Beyond September 30 are Invalid: NMC warns all the states

Powered by WPeMatico

Parents of RG Kar victim seek fresh investigation from Calcutta HC

The parents of the doctor who was raped and murdered at RG Kar Medical College and Hospital have filed a petition in the Calcutta High Court demanding a fresh investigation into their daughter’s tragic death.

Expressing a lack of confidence in the ongoing probe into the incident that led to huge protests, they prayed for a direction for a fresh investigation into the rape and murder of their daughter.

For more information, click on the link below:

Powered by WPeMatico

Telangana HC strikes down GO restricting local candidate status for PG medical admissions

In a major relief to the medicos who pursued their MBBS degrees in Telangana but completed their schooling from outside the State, the Telangana High Court has allowed them for postgraduate (PG) medical counselling within the State as local candidates.

Accordingly, the HC bench comprising Chief Justice Alok Aradhe and Justice J Sreenivas struck down Government Order No. 148 and 149, which mandate that the students complete their schooling within Telangana to be considered local residents.

For more information, click on the link below:

Powered by WPeMatico

NPPA Turns to Patent Office for Clarity on Drug Price Exemptions, Defers Intas, Biological E’s Applications

New Delhi: The National Pharmaceutical Pricing Authority (NPPA) has sought expertise from the Indian Patent Office to assist in making decisions regarding pharma firms seeking exemptions from price controls under the Drug Price Control Order (DPCO) 2013.

This decision to involve experts from the Patent Office is expected to ensure more informed decision-making, though pharma companies seeking price exemptions will face intense scrutiny.

During its meeting held in early December, the NPPA deferred decisions on exemption applications from Intas Pharmaceuticals and Biological E, pending further evaluation.

Intas Pharmaceuticals applied for an exemption for its antipsychotic formulation, Clozapine Extended Release Capsules (ranging from 12.5 mg to 200 mg). The company argued that the drug, developed through indigenous research and patented in India (Patent No. 437433, granted on July 5, 2023), qualifies for an exemption under Paragraph 32 of the DPCO 2013. This provision exempts drugs developed using a unique, indigenous process, patented under the Indian Patents Act, and not manufactured elsewhere.

Similarly, Biological E sought exemption for its Pneumococcal Polysaccharide Conjugate Vaccine (PNEUBEVAX 14), claiming that its novel development and patent status meet the criteria for exemption.

When reviewing the applications, the Committee recalled its decision from the 44th meeting of the MDC on August 4, 2022. At that time, the Committee had determined that various drug variants, such as extended-release and modified-release formulations, had been available in the market for a long time and were produced by several companies. As a result, these formulations could not be considered a “New Delivery System” eligible for exemption under Para 32 (iii) of the DPCO, 2013. Consequently, the Committee rejected Intas Pharmaceuticals’ application for exemption from price control provisions for Clozapine Extended Release Capsules.

In response, Intas Pharmaceuticals reiterated that its formulation should be exempt from DPCO 2013, as it was developed using a new, indigenous process and patented under the Indian Patents Act, 1970. The company submitted the necessary DCGI approval, along with the patent certificate (Patent no. 437433), granted on July 5, 2023, including the complete specifications and claims on which the patent was granted.

The Committee also recalled its decision from the 61st meeting on August 14, 2024, which outlined that for matters related to exemptions under Para 32 of DPCO 2013, an officer from the Office of the Controller General of Patents, Designs & Trade Marks (CGPDTM), DPIIT, not below the rank of Deputy Controller, would be invited to participate in deliberations. The agenda for these deliberations would be sent in advance to CGPDTM. This decision was endorsed by the Authority during its 126th meeting on September 9, 2024.

Following this, the agenda for the subject matter was sent to DPIIT via a letter dated November 8, 2024, requesting the nomination of an officer to participate in the MDC meeting. A copy of the letter was also sent to CGPDTM, and reminders were issued on December 3 and December 5, 2024. However, no nomination has been received from DPIIT to date. As a result, the Committee decided to defer the agenda item and urged DPIIT to expedite the nomination process so that the matter can be discussed at the next meeting.

Also Read: Intas Pharmaceutical Gets CDSCO Panel Nod To Manufacture, Market Anti-cancer Drug Pertuzumab

In the case of Biological E, the Committee reiterated the same decision from the 61st meeting regarding the involvement of an officer from the CGPDTM. The agenda for deliberations was also sent to DPIIT on December 3, 2024, with a reminder on December 5, 2024. However, as with Intas Pharmaceuticals, no nomination has been received. Consequently, the Committee decided to defer this agenda item as well and emphasized the need for a suitable nomination from DPIIT to proceed.

Despite multiple communications, the Department for Promotion of Industry and Internal Trade (DPIIT) has yet to nominate an officer from the Patent Office to participate in these critical deliberations. As a result, both agenda items have been deferred, with the Committee stressing the importance of expert input before making any decisions.

Subsequently, the Committee decided;

“To defer the agenda item and requested that the matter may be pursued with DPIIT for the nomination of a suitable officer so that the matter can be deliberated in the next meeting.”

Powered by WPeMatico

Autism spectrum disorder ranks among top 10 causes of non-fatal health burden in youth, global study shows

A new global analysis reveals that an estimated 61.8 million people in 2021 were autistic —equivalent to one in every 127 individuals. Conducted as part of the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021, the research identifies autism spectrum disorder (ASD) as one of the top ten causes of non-fatal health burden for youth under 20 years old.

Powered by WPeMatico

There are more heart attacks on Christmas than any other day of the year

We sing about how Christmas brings “tidings of comfort and joy,” but the holiday also brings something not so “merry and bright.”

Powered by WPeMatico

Getting rehab earlier improves concussion outcomes, study suggests

People who suffer from continued symptoms of concussion should seek a referral to physical therapy as soon as possible, new research from Oregon Health & Science University suggests.

Powered by WPeMatico

Snack bars out, salmon in: US revamps ‘healthy’ food labels

The United States has redefined what qualifies as “healthy” food for the first time in 30 years, striking items like white bread from the list while welcoming nutrient-rich options such as eggs and salmon, officials said Thursday.

Powered by WPeMatico